Literature DB >> 28405988

A Study of salt and fat Consumption pattern in Regional Indian diet among hypertensive and dyslipidemic PaTients - SCRIPT study.

Dayanand Kumbla1, Mala Dharmalingam2, Kalpesh Dalvi3, Saumitra Ray4, Mahesh K Shah5, Sanjay Gupta6, S Sadhanandham7, A K Ajmani8, Sanjay Nag9, Srinivas Murthy10, Mohana Murugan11, Abhijit Trailokya3, Tushar Fegade3.   

Abstract

BACKGROUND: Cardiovascular diseases are leading cause of mortality and morbidity. There is an increasing prevalence of hypertension and dyslipidemia due to globalization and adoption of westernized dietary habits in India. These transitions are manifest in dietary patterns and health outcomes.
OBJECTIVE: To study the dietary salt and fat intake among patients diagnosed with hypertension and dyslipidemia in India.
METHODS: SCRIPT study was a pilot exploratory, cross-sectional, observational, descriptive, multi-center study. It was conducted across hospitals and clinics in five metro cities of India, represented into four regional zones. In each region (North, n = 113; East, n = 98; West, n = 83; South, n = 152), patients diagnosed with hypertension and dyslipidemia were enrolled in the study. Socio-demographic and treatment details were recorded. Participants were interviewed by a dietician and their dietary intake was assessed by a three-day recall of food item questionnaire/ food diary.
RESULTS: Overall the mean total daily salt consumption was 10.9 grams. Region-wise, the mean daily salt consumption in North, East, West and South were 14.13, 9.81, 10.12 and 9.38 grams respectively. The daily salt consumption in the North was significantly higher than other regions (P=0.012). The daily consumption of saturated fats (total saturated fat, ghee and butter) in the North was higher and statistically significantly in comparison to West, South and East (P <0.05). Overall, fats contributed to 24.1%, proteins contributed to 12.7% and carbohydrate contributed to 63.2% of total energy per day. The percentage of fat and protein contributing to total energy per day was within the acceptable range.
CONCLUSIONS: Our study documented higher dietary salt intake than that recommended in India. There is an urgent need to address the issue of high salt and saturated fat consumption. Nutritional strategies for reducing salt intake, saturated fat and balancing energy nutrients should be urgently applied in Indian hypertensive and dyslipidemia patients.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 28405988

Source DB:  PubMed          Journal:  J Assoc Physicians India        ISSN: 0004-5772


  5 in total

Review 1.  Indian guidelines on hypertension-IV (2019).

Authors:  Siddharth N Shah; Y P Munjal; Sandhya A Kamath; Gurpreet S Wander; Nihar Mehta; Sukumar Mukherjee; Ashok Kirpalani; Pritam Gupta; Hardik Shah; Ragini Rohatgi; Aspi R Billimoria; M Maiya; Mrinal Kanti Das; Kewal C Goswami; Rajan Sharma; Mohan M Rajapurkar; Rajeev Chawla; Banshi Saboo; Vivekanand Jha
Journal:  J Hum Hypertens       Date:  2020-05-19       Impact factor: 3.012

Review 2.  Heterogeneity of Dietary practices in India: current status and implications for the prevention and control of type 2 diabetes.

Authors:  Meenakshi Sachdev; Anoop Misra
Journal:  Eur J Clin Nutr       Date:  2022-01-17       Impact factor: 4.884

3.  Salt consumption and the risk of chronic diseases among Chinese adults in Ningbo city.

Authors:  Yi Lin; Qiuhong Mei; Xujun Qian; Tianfeng He
Journal:  Nutr J       Date:  2020-01-29       Impact factor: 3.271

Review 4.  Salt intake and salt-reduction strategies in South Asia: From evidence to action.

Authors:  Kamal Ghimire; Shiva Raj Mishra; Gautam Satheesh; Dinesh Neupane; Abhishek Sharma; Rajmohan Panda; Per Kallestrup; Craig S Mclachlan
Journal:  J Clin Hypertens (Greenwich)       Date:  2021-09-09       Impact factor: 3.738

5.  Blood pressure - Methods to record & numbers that are significant: Lets make a tailored suit to suit us.

Authors:  Gurpreet Singh Wander; C Venkata S Ram
Journal:  Indian J Med Res       Date:  2018-05       Impact factor: 2.375

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.